A user facility clinical manager reported that a dialyzer blood leak occurred immediately after the initiation of the patient¿s hemodialysis (hd) treatment.The blood leak was noted as being an external blood leak.The leak was visually observed at the header cap of the dialyzer.The machine, a fresenius 2008t machine, alarmed appropriately with a blood leak alarm.Blood leak test strips were not used because the leak was visually observed at the header cap of the dialyzer.There was damage seen on the header cap of the dialyzer.The patient¿s estimated blood loss (ebl) was approximately 200 ml.There was no patient injury or medical intervention required as a result of this event.The patient was restarted on the same machine and treatment completed successfully with new supplies.The complaint device was reported to be available to be returned to the manufacturer for evaluation.
|
Plant investigation: although it was indicated the sample is available, no sample has been provided for evaluation as of 11/28/2022.According to the third-party carrier's website, the fmcna-provided shipping materials were sent to the customer and subsequently received.The reported complaint could not be confirmed, as a definitive conclusion regarding the complaint incident cannot be reached based on the limited information provided.During the lot history review it was noted that there were two other complaints reported against the lot.Both address internal blood leaks (no samples) and are unrelated to the current event.A review of the production record was performed.The production record review showed there was one unrelated approved temporary dn in the production of this lot.There was no indication of product non-acceptance or deviation in the manufacturing process related to the complaint event.This includes non-conformances, rework, labeling, process controls, and any other occurrence in production that was potentially related to the complaint.The reported lot number passed pyrogen testing, was within sterilization dosage parameters and passed all release criteria.Continuous improvement is of the utmost importance to fresenius medical care as we strive to provide dialysis products of the highest quality to our patients.Reports of leaking product are investigated both individually as complaints, as well as via the nc/capa program, in order to assess and improve our products and processes.Capas (vision systems) and (blood leak reduction) are recent examples of leak related investigations directed at an overall reduction in dialyzer leaks.The lot met all release criteria.A definitive conclusion regarding the complaint incident cannot be reached without physical examination of the actual device.Therefore, the complaint is not confirmed.
|